Sarah is originally from New Zealand where she completed a PhD in Neuroscience that involved the development of a model of hypoxic brain injury suffered by infants that were born extremely prematurely.
Since moving to the United Kingdom in 2011 after the completion of her PhD, Sarah was appointed as a Research Fellow based in the Children's Brain Tumour Research Team at the University of Birmingham. Since then she has worked on several childhood cancer projects including retinoblastoma, neuroblastoma, and medulloblastoma. Sarah is interested in exploring the biological and metabolic processes that underlie these tumours, and much of her research involves investigating the potential for the metabolic stratification of tumours into the biological and/or genetic sub-groups that may aid in predicting prognostic outcome and survival. She also has an interest in the identification and evaluation of potential biomarkers of clinical outcome in paediatric tumours along with an interest in the interaction between lipids and glutamine in cancer metabolism.
Sarah is experienced in several key laboratory techniques including standard histology procedures, immunohistochemistry in both frozen and paraffin embedded tissue, microscopy, cell culture, and nuclear magnetic resonance (NMR) spectroscopy of tumour tissue, specifically high resolution magic angle spinning (HRMAS).